Cultivar

 

Breeder Seed

1Involves PepsiCo (Quaker)

2Licensee will produce breeder seed in collaboration with the breeder

  • breeder seed available in 2019
  • breeder seed available in 2019
  • see note below

Proposals will be received until 5:00 p.m., March 29, 2018. Please send your proposals to:

Kofi Agblor, Managing Director
Crop Development Centre
51 Campus Drive
University of Saskatchewan
Saskatoon, SK S7N 5A8
kofi.agblor@usask.ca

 Proposals should provide evidence of a satisfactory history of arranging for pedigreed seed production, ability to arrange a suitable seed marketing system, up-front license fees and royalty amounts offered (minimum acceptable royalty is 6% of retail pedigreed seed price or equivalent value per Tonne), and ability to collect royalties on behalf of the University of Saskatchewan.  All proposals should include a copy of the proponent’s most recent annual report including financial information.  If no annual report is available, a copy of the balance sheet for the most recent fiscal year will be accepted.  Exclusive pedigreed seed marketing rights for each cultivar will be awarded on the basis of demonstrated expertise, realistic business plans for increasing, promoting, distributing and marketing of pedigreed seed, willingness to pay registration and regional trialing fees, benefit to Saskatchewan and western Canada, and returns to the CDC. Proposals should also provide the amount of breeder seed needed to meet seed multiplication targets.  All proposals should clearly state whether or not the proponent wishes to obtain Plant Breeders’ Rights protection for the variety at the proponent’s cost.  E-mailed proposals received by the deadline are acceptable but must be followed by a signed original.  Applicants are encouraged to obtain performance data and information unique to each cultivar from the Crop Development Centre at the above address, by fax or email request, or from the CDC website:

http://agbio.usask.ca/index.php?page=crop-development-centre

The CDC reserves the right to reject any or all proposals.  Proponents of proposals accepted by the CDC will be invited to discuss substantive licensing terms to be concluded within 90 days of the award; however, finalization of a license agreement is not assured.